99 related articles for article (PubMed ID: 2838061)
1. Estrogen replacement therapy and fibrocystic breast disease.
Pastides H; Najjar MA; Kelsey JL
Am J Prev Med; 1987; 3(5):282-6. PubMed ID: 2838061
[TBL] [Abstract][Full Text] [Related]
2. Estrogen replacement therapy and benign breast disease.
Trapido EJ; Brinton LA; Schairer C; Hoover R
J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
[TBL] [Abstract][Full Text] [Related]
3. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
4. Estrogen replacement therapy and risk of Alzheimer disease.
Paganini-Hill A; Henderson VW
Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
[TBL] [Abstract][Full Text] [Related]
5. Conjugated estrogens and fibrocystic breast disease.
Jick SS; Walker AM; Jick H
Am J Epidemiol; 1986 Nov; 124(5):746-51. PubMed ID: 3020976
[TBL] [Abstract][Full Text] [Related]
6. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
Vassilopoulou-Sellin R; Theriault RL
J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
[TBL] [Abstract][Full Text] [Related]
7. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
9. Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women.
Berkowitz GS; Kelsey JL; Holford TR; LiVolsi VA; Merino MJ; Beck GJ; Ort S; O'Connor TZ; White C
Am J Epidemiol; 1985 Feb; 121(2):238-45. PubMed ID: 4014118
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for fibrocystic breast disease and its histopathologic components.
Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
[TBL] [Abstract][Full Text] [Related]
11. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement treatment and breast cancer risk: an age-specific analysis.
Tavani A; Braga C; La Vecchia C; Negri E; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):11-4. PubMed ID: 8993791
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
[TBL] [Abstract][Full Text] [Related]
15. The new conundrum: do estrogens have any cardiovascular benefits?
Clarkson TB
Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and the menopause: a global overview.
Barrett-Connor E
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():6-14. PubMed ID: 8499961
[TBL] [Abstract][Full Text] [Related]
17. [Replacement therapy in menopause and risk for breast tumors].
Franceschi S
Ann Ist Super Sanita; 1997; 33(2):207-11. PubMed ID: 9470242
[TBL] [Abstract][Full Text] [Related]
18. Venous thrombosis and conjugated equine estrogen in women without a uterus.
Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
20. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
